+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rexahn Pharmaceuticals Inc - logo

Rexahn Pharmaceuticals Inc - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.
From
From
From
From
Bladder Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 999 Pages
From
Bladder Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H2 2017

  • Drug Pipelines
  • 937 Pages
From
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2509 Pages
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2412 Pages
From
Colon Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 782 Pages
From
Colorectal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2237 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2011 Pages
From
From
From
From
From
Cervical Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 768 Pages
From
From
From
Akt1 Inhibitor -Pipeline Insight, 2019 - Product Thumbnail Image

Akt1 Inhibitor -Pipeline Insight, 2019

  • Drug Pipelines
  • 120 Pages
From
Loading Indicator
adroll